325 related articles for article (PubMed ID: 34835997)
1. Potential Protective Effects of Equol (Soy Isoflavone Metabolite) on Coronary Heart Diseases-From Molecular Mechanisms to Studies in Humans.
Zhang X; Veliky CV; Birru RL; Barinas-Mitchell E; Magnani JW; Sekikawa A
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34835997
[TBL] [Abstract][Full Text] [Related]
2. Effect of S-equol and Soy Isoflavones on Heart and Brain.
Sekikawa A; Ihara M; Lopez O; Kakuta C; Lopresti B; Higashiyama A; Aizenstein H; Chang YF; Mathis C; Miyamoto Y; Kuller L; Cui C
Curr Cardiol Rev; 2019; 15(2):114-135. PubMed ID: 30516108
[TBL] [Abstract][Full Text] [Related]
3. Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial.
Hazim S; Curtis PJ; Schär MY; Ostertag LM; Kay CD; Minihane AM; Cassidy A
Am J Clin Nutr; 2016 Mar; 103(3):694-702. PubMed ID: 26843154
[TBL] [Abstract][Full Text] [Related]
4. Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia.
Sekikawa A; Wharton W; Butts B; Veliky CV; Garfein J; Li J; Goon S; Fort A; Li M; Hughes TM
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233223
[TBL] [Abstract][Full Text] [Related]
5. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.
Setchell KD; Brown NM; Lydeking-Olsen E
J Nutr; 2002 Dec; 132(12):3577-84. PubMed ID: 12468591
[TBL] [Abstract][Full Text] [Related]
6. Research protocol: effect of natural S-equol on blood pressure and vascular function--a six-month randomized controlled trial among equol non-producers of postmenopausal women with prehypertension or untreated stage 1 hypertension.
Liu ZM; Ho SC; Chen YM; Xie YJ; Huang ZG; Ling WH
BMC Complement Altern Med; 2016 Mar; 16():89. PubMed ID: 26928904
[TBL] [Abstract][Full Text] [Related]
7. Equol Decreases Hot Flashes in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Daily JW; Ko BS; Ryuk J; Liu M; Zhang W; Park S
J Med Food; 2019 Feb; 22(2):127-139. PubMed ID: 30592686
[TBL] [Abstract][Full Text] [Related]
8. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
9. Soy-derived isoflavones exert opposing actions on Guinea pig ventricular myocytes.
Liew R; Williams JK; Collins P; MacLeod KT
J Pharmacol Exp Ther; 2003 Mar; 304(3):985-93. PubMed ID: 12604673
[TBL] [Abstract][Full Text] [Related]
10. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
North American Menopause Society
Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.
Yuan JP; Wang JH; Liu X
Mol Nutr Food Res; 2007 Jul; 51(7):765-81. PubMed ID: 17579894
[TBL] [Abstract][Full Text] [Related]
12. Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights.
Jackman KA; Woodman OL; Sobey CG
Curr Med Chem; 2007; 14(26):2824-30. PubMed ID: 18045128
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of soy isoflavone-glycosides in laying hens: intestinal absorption and preferential accumulation into egg yolk of equol, a more estrogenic metabolite of daidzein.
Saitoh S; Sato T; Harada H; Matsuda T
Biochim Biophys Acta; 2004 Sep; 1674(2):122-30. PubMed ID: 15374616
[TBL] [Abstract][Full Text] [Related]
14. Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention?
Tikkanen MJ; Adlercreutz H
Biochem Pharmacol; 2000 Jul; 60(1):1-5. PubMed ID: 10807939
[TBL] [Abstract][Full Text] [Related]
15. Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic risk.
Reverri EJ; LaSalle CD; Franke AA; Steinberg FM
Mol Nutr Food Res; 2015 Feb; 59(2):323-33. PubMed ID: 25351805
[TBL] [Abstract][Full Text] [Related]
16. Roles of Phytoestrogen in the Pathophysiology of Intracranial Aneurysm.
Yokosuka K; Rutledge C; Kamio Y; Kuwabara A; Sato H; Rahmani R; Purcell J; Eguchi S; Baranoski JF; Margaryan T; Tovmasyan A; Ai J; Lawton MT; Hashimoto T
Stroke; 2021 Aug; 52(8):2661-2670. PubMed ID: 34157864
[TBL] [Abstract][Full Text] [Related]
17. Soy Isoflavones Inhibit Endothelial Cell Dysfunction and Prevent Cardiovascular Disease.
Yamagata K
J Cardiovasc Pharmacol; 2019 Sep; 74(3):201-209. PubMed ID: 31356541
[TBL] [Abstract][Full Text] [Related]
18. Understanding the cardiovascular actions of soy isoflavones: potential novel targets for antihypertensive drug development.
Martin D; Song J; Mark C; Eyster K
Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):297-312. PubMed ID: 19202595
[TBL] [Abstract][Full Text] [Related]
19. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
[TBL] [Abstract][Full Text] [Related]
20. Effect of soy isoflavone supplementation on endothelial dysfunction and oxidative stress in equol-producing postmenopausal women.
Pusparini ; Yenny ; Hidayat A
Endocr Metab Immune Disord Drug Targets; 2015; 15(1):71-9. PubMed ID: 25441486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
